Gene Symbol | Gene ID | Gene Info |
---|---|---|
Isl1
|
ENSMUSG00000042258.7 | ISL1 transcription factor, LIM/homeodomain |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_116305222_116305373 | Isl1 | 1100 | 0.569857 | 0.80 | 4.0e-13 | Click! |
chr13_116297196_116297347 | Isl1 | 6080 | 0.248985 | 0.71 | 1.5e-09 | Click! |
chr13_116309234_116309535 | Isl1 | 38 | 0.981295 | 0.70 | 2.8e-09 | Click! |
chr13_116304768_116305058 | Isl1 | 1484 | 0.463314 | 0.69 | 5.5e-09 | Click! |
chr13_116293962_116294162 | Isl1 | 9289 | 0.236979 | 0.58 | 2.7e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_64595318_64595919 | 33.85 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr13_39524261_39524439 | 33.21 |
Gm47351 |
predicted gene, 47351 |
8753 |
0.2 |
chr5_149527921_149528686 | 33.19 |
Wdr95 |
WD40 repeat domain 95 |
376 |
0.81 |
chrX_13346707_13347908 | 29.20 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr18_81830833_81831208 | 28.62 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr4_65888333_65888871 | 26.62 |
Trim32 |
tripartite motif-containing 32 |
283353 |
0.01 |
chr6_96286333_96286534 | 25.84 |
1700123L14Rik |
RIKEN cDNA 1700123L14 gene |
120190 |
0.06 |
chr5_85239463_85240008 | 25.43 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr18_45896851_45897467 | 25.33 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr2_43978848_43979182 | 25.13 |
Arhgap15 |
Rho GTPase activating protein 15 |
86026 |
0.1 |
chr3_66326110_66326323 | 25.06 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29379 |
0.18 |
chr8_61325062_61325301 | 24.57 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
36309 |
0.13 |
chr9_15866407_15866579 | 24.50 |
Mtnr1b |
melatonin receptor 1B |
7967 |
0.23 |
chr7_109165964_109166186 | 23.95 |
Lmo1 |
LIM domain only 1 |
4437 |
0.2 |
chr11_58400392_58400572 | 23.95 |
Gm12252 |
predicted gene 12252 |
3967 |
0.11 |
chr2_35849935_35850217 | 23.55 |
Gm10829 |
predicted gene 10829 |
5881 |
0.2 |
chr3_40070102_40070729 | 23.40 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr2_21060324_21060508 | 23.09 |
Gm13376 |
predicted gene 13376 |
36683 |
0.16 |
chr4_79530917_79531075 | 22.98 |
Gm11263 |
predicted gene 11263 |
203288 |
0.03 |
chr10_92162409_92163019 | 22.20 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr8_45508006_45508255 | 22.07 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
212 |
0.94 |
chr13_83749525_83749738 | 22.05 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10768 |
0.12 |
chr4_71484616_71485009 | 21.71 |
Rps18-ps1 |
ribosomal protein S18, pseudogene 1 |
113616 |
0.07 |
chr10_16052455_16052829 | 21.29 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
260865 |
0.02 |
chr1_192755693_192756022 | 21.19 |
Gm22265 |
predicted gene, 22265 |
10286 |
0.17 |
chr8_33747412_33747586 | 21.05 |
Smim18 |
small integral membrane protein 18 |
271 |
0.88 |
chr17_76111639_76112128 | 20.94 |
Gm24126 |
predicted gene, 24126 |
37337 |
0.22 |
chr5_35454198_35454812 | 20.89 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr3_45385015_45385410 | 20.40 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chr1_51650752_51650944 | 20.31 |
Gm28055 |
predicted gene 28055 |
47052 |
0.14 |
chr3_68824497_68825036 | 20.28 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr12_44839950_44840386 | 20.21 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr10_37378009_37378297 | 20.19 |
Gm26535 |
predicted gene, 26535 |
40667 |
0.19 |
chr12_17048993_17049526 | 20.11 |
Gm48538 |
predicted gene, 48538 |
16154 |
0.17 |
chr17_9543267_9543689 | 19.80 |
Gm49807 |
predicted gene, 49807 |
6213 |
0.28 |
chr7_92258664_92258972 | 19.72 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
23691 |
0.23 |
chr19_26770137_26770516 | 19.70 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr16_89538151_89538450 | 19.61 |
Krtap7-1 |
keratin associated protein 7-1 |
29977 |
0.13 |
chr10_52742737_52743261 | 19.54 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr2_146724257_146724438 | 19.50 |
Gm14111 |
predicted gene 14111 |
31358 |
0.22 |
chr3_127294086_127294512 | 19.19 |
Gm42970 |
predicted gene 42970 |
5374 |
0.15 |
chr13_72028642_72028801 | 19.15 |
Irx1 |
Iroquois homeobox 1 |
64998 |
0.13 |
chr16_25016242_25016817 | 19.03 |
A230028O05Rik |
RIKEN cDNA A230028O05 gene |
43110 |
0.19 |
chr2_63963076_63963322 | 18.76 |
Fign |
fidgetin |
134789 |
0.06 |
chr13_83661208_83661451 | 18.70 |
Mef2c |
myocyte enhancer factor 2C |
8441 |
0.18 |
chr15_50735926_50736259 | 18.45 |
Trps1 |
transcriptional repressor GATA binding 1 |
91429 |
0.09 |
chr8_61515184_61515647 | 18.43 |
Palld |
palladin, cytoskeletal associated protein |
485 |
0.84 |
chr6_49021447_49021653 | 18.31 |
Gpnmb |
glycoprotein (transmembrane) nmb |
14996 |
0.08 |
chr9_90693284_90693632 | 18.31 |
Gm2497 |
predicted gene 2497 |
40066 |
0.15 |
chr18_57262231_57262735 | 18.28 |
Gm50200 |
predicted gene, 50200 |
52657 |
0.11 |
chr18_40796377_40796528 | 18.25 |
Rps19-ps13 |
ribosomal protein S19, pseudogene 13 |
70183 |
0.11 |
chr11_47264465_47264671 | 18.23 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
114954 |
0.07 |
chr8_78556826_78557206 | 18.20 |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
20735 |
0.18 |
chr5_9345097_9345292 | 18.20 |
Gm15733 |
predicted gene 15733 |
8565 |
0.2 |
chr15_37135024_37136161 | 18.11 |
Gm9509 |
predicted gene 9509 |
36812 |
0.14 |
chr7_49699439_49699606 | 18.00 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59593 |
0.11 |
chr7_88261931_88262082 | 17.91 |
Ctsc |
cathepsin C |
16079 |
0.22 |
chr16_63278367_63278696 | 17.77 |
Gm33912 |
predicted gene, 33912 |
61089 |
0.15 |
chr11_82579895_82580440 | 17.76 |
Gm24612 |
predicted gene, 24612 |
16012 |
0.2 |
chr17_66869624_66870037 | 17.75 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chrX_101987046_101987197 | 17.73 |
Nhsl2 |
NHS-like 2 |
17923 |
0.15 |
chr13_58971668_58972019 | 17.72 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
100108 |
0.06 |
chr15_36967359_36968246 | 17.72 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr2_10525644_10525960 | 17.70 |
Mir669h |
microRNA 669h |
7647 |
0.01 |
chr17_78501306_78501507 | 17.60 |
Vit |
vitrin |
6658 |
0.17 |
chr3_102980219_102980386 | 17.51 |
Sike1 |
suppressor of IKBKE 1 |
15406 |
0.12 |
chr4_55929493_55929703 | 17.43 |
Gm12519 |
predicted gene 12519 |
64141 |
0.14 |
chrX_161524009_161524161 | 17.41 |
Prkaca-ps1 |
protein kinase, cAMP dependent, catalytic, alpha pseudogene 1 |
37600 |
0.22 |
chr13_6306939_6307331 | 17.26 |
Gm35615 |
predicted gene, 35615 |
12421 |
0.23 |
chr3_145825482_145825700 | 17.24 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
15112 |
0.2 |
chr16_39287252_39287499 | 17.20 |
Gm36742 |
predicted gene, 36742 |
98469 |
0.08 |
chr7_131778146_131778326 | 17.18 |
Gm44547 |
predicted gene 44547 |
8343 |
0.22 |
chr13_28295576_28295772 | 17.14 |
Gm47172 |
predicted gene, 47172 |
10105 |
0.23 |
chr9_84253597_84253862 | 17.10 |
Gm26146 |
predicted gene, 26146 |
65374 |
0.12 |
chr8_45507619_45508001 | 16.90 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
2 |
0.98 |
chr16_42339557_42339849 | 16.89 |
Gap43 |
growth associated protein 43 |
948 |
0.66 |
chr6_47228750_47229021 | 16.73 |
Cntnap2 |
contactin associated protein-like 2 |
15502 |
0.28 |
chr2_105674521_105675719 | 16.64 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr18_42704653_42704822 | 16.51 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
82278 |
0.08 |
chr6_77243554_77244106 | 16.49 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
908 |
0.69 |
chr3_104058968_104059448 | 16.48 |
Gm42696 |
predicted gene 42696 |
1067 |
0.33 |
chr2_181766899_181767258 | 16.43 |
Myt1 |
myelin transcription factor 1 |
36 |
0.97 |
chr6_5408845_5409023 | 16.43 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
18507 |
0.23 |
chr9_71879542_71879779 | 16.37 |
Tcf12 |
transcription factor 12 |
5051 |
0.13 |
chr12_56458764_56459233 | 16.33 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr17_43158272_43158631 | 16.14 |
E130008D07Rik |
RIKEN cDNA E130008D07 gene |
160 |
0.97 |
chr4_71485302_71485664 | 16.10 |
Rps18-ps1 |
ribosomal protein S18, pseudogene 1 |
114287 |
0.07 |
chr13_56774410_56774604 | 16.07 |
Gm45623 |
predicted gene 45623 |
20680 |
0.21 |
chr6_8294057_8294761 | 16.03 |
Umad1 |
UMAP1-MVP12 associated (UMA) domain containing 1 |
23943 |
0.14 |
chr18_30197602_30197916 | 15.91 |
Gm49980 |
predicted gene, 49980 |
69490 |
0.12 |
chr13_34129793_34130880 | 15.86 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr12_58670274_58670654 | 15.85 |
Gm18873 |
predicted gene, 18873 |
93442 |
0.08 |
chr6_8352593_8352826 | 15.75 |
Gm16055 |
predicted gene 16055 |
11427 |
0.18 |
chr12_77739490_77739672 | 15.65 |
4930458K08Rik |
RIKEN cDNA 4930458K08 gene |
56520 |
0.12 |
chr7_73637071_73637452 | 15.58 |
Gm44737 |
predicted gene 44737 |
6644 |
0.1 |
chr3_26835054_26835226 | 15.53 |
Gm37659 |
predicted gene, 37659 |
177624 |
0.03 |
chr6_32373945_32374204 | 15.51 |
Plxna4os3 |
plexin A4, opposite strand 3 |
70161 |
0.11 |
chr2_64706718_64706919 | 15.47 |
Gm13576 |
predicted gene 13576 |
136178 |
0.05 |
chr3_26641406_26641733 | 15.30 |
Spata16 |
spermatogenesis associated 16 |
3919 |
0.29 |
chr14_46077518_46077669 | 15.30 |
Ubb-ps |
ubiquitin B, pseudogene |
6435 |
0.2 |
chr15_10421430_10421775 | 15.29 |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
28390 |
0.15 |
chr2_74426718_74427115 | 15.25 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr4_110209740_110209990 | 15.22 |
Elavl4 |
ELAV like RNA binding protein 4 |
13283 |
0.29 |
chr6_98046634_98046821 | 15.20 |
Mitf |
melanogenesis associated transcription factor |
54806 |
0.15 |
chr14_35095601_35095765 | 15.18 |
Gm49034 |
predicted gene, 49034 |
123755 |
0.06 |
chr11_24363754_24364273 | 15.17 |
Gm12068 |
predicted gene 12068 |
62233 |
0.12 |
chr7_19175722_19176163 | 15.14 |
Eml2 |
echinoderm microtubule associated protein like 2 |
479 |
0.59 |
chr10_23016379_23016546 | 15.01 |
Gm47787 |
predicted gene, 47787 |
59878 |
0.13 |
chr3_17616549_17616970 | 14.94 |
Gm38154 |
predicted gene, 38154 |
53929 |
0.16 |
chr6_58837806_58838284 | 14.94 |
Herc3 |
hect domain and RLD 3 |
4345 |
0.25 |
chr15_103519338_103519794 | 14.88 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr9_124439329_124439899 | 14.84 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1254 |
0.4 |
chr11_71414747_71415135 | 14.80 |
Gm16013 |
predicted gene 16013 |
21239 |
0.21 |
chr12_5144239_5144620 | 14.76 |
Gm9110 |
predicted gene 9110 |
76981 |
0.09 |
chr13_83984413_83984945 | 14.72 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr10_87486341_87486591 | 14.70 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7194 |
0.2 |
chr16_63806861_63807216 | 14.68 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr19_14777197_14777401 | 14.64 |
Gm26026 |
predicted gene, 26026 |
58819 |
0.15 |
chr5_42068234_42068511 | 14.59 |
Gm16223 |
predicted gene 16223 |
412 |
0.91 |
chr13_76802462_76802613 | 14.58 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
22670 |
0.24 |
chr16_77537354_77537608 | 14.57 |
Gm36963 |
predicted gene, 36963 |
2401 |
0.2 |
chr1_127531215_127531971 | 14.55 |
Tmem163 |
transmembrane protein 163 |
5837 |
0.29 |
chr3_31309752_31310443 | 14.47 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
281 |
0.81 |
chr8_31091237_31091775 | 14.46 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
144 |
0.96 |
chr9_52278418_52278613 | 14.45 |
Gm25562 |
predicted gene, 25562 |
12684 |
0.22 |
chr6_22834243_22834395 | 14.42 |
Gm43629 |
predicted gene 43629 |
28990 |
0.15 |
chr2_130352053_130352242 | 14.40 |
Gm14044 |
predicted gene 14044 |
33182 |
0.07 |
chr2_144127511_144127732 | 14.38 |
Gm11687 |
predicted gene 11687 |
15752 |
0.16 |
chr12_33035669_33036432 | 14.31 |
Cdhr3 |
cadherin-related family member 3 |
16936 |
0.14 |
chr7_62046082_62046717 | 14.28 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr10_27468497_27468689 | 14.28 |
Gm23353 |
predicted gene, 23353 |
16304 |
0.24 |
chr2_62047014_62047411 | 14.22 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
567 |
0.84 |
chr10_104686774_104686997 | 14.18 |
Gm25522 |
predicted gene, 25522 |
178423 |
0.03 |
chr4_28935550_28935919 | 14.16 |
Epha7 |
Eph receptor A7 |
63810 |
0.13 |
chr9_27298463_27299015 | 14.13 |
Igsf9b |
immunoglobulin superfamily, member 9B |
465 |
0.82 |
chr7_112535354_112535706 | 14.12 |
Parvaos |
parvin, alpha, opposite strand |
153 |
0.96 |
chr10_39227529_39227710 | 14.11 |
Gm31562 |
predicted gene, 31562 |
17427 |
0.16 |
chr7_51784054_51784235 | 14.01 |
Gm29296 |
predicted gene 29296 |
11418 |
0.17 |
chr13_79430948_79431368 | 14.01 |
Gm48470 |
predicted gene, 48470 |
10249 |
0.24 |
chr5_112481948_112482441 | 13.98 |
Sez6l |
seizure related 6 homolog like |
7067 |
0.17 |
chr18_23394845_23395028 | 13.95 |
Dtna |
dystrobrevin alpha |
20199 |
0.27 |
chr3_85764601_85764835 | 13.94 |
Fam160a1 |
family with sequence similarity 160, member A1 |
18452 |
0.2 |
chr2_97478952_97479288 | 13.91 |
Lrrc4c |
leucine rich repeat containing 4C |
11031 |
0.3 |
chr2_179481364_179481534 | 13.88 |
Cdh4 |
cadherin 4 |
37216 |
0.18 |
chr14_75566269_75566669 | 13.88 |
Cby2 |
chibby family member 2 |
25480 |
0.19 |
chr4_110153152_110153342 | 13.79 |
Elavl4 |
ELAV like RNA binding protein 4 |
69901 |
0.13 |
chr2_146723162_146723336 | 13.77 |
Gm14111 |
predicted gene 14111 |
32456 |
0.21 |
chr1_18191166_18191317 | 13.75 |
Defb44-ps |
defensin beta 44, pseudogene |
32323 |
0.14 |
chr11_117454302_117454453 | 13.75 |
Gm11732 |
predicted gene 11732 |
28199 |
0.11 |
chr3_8510380_8510590 | 13.73 |
Stmn2 |
stathmin-like 2 |
899 |
0.63 |
chr5_111220876_111221370 | 13.72 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4335 |
0.22 |
chr3_62454253_62454452 | 13.71 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
18235 |
0.22 |
chr18_74956461_74956661 | 13.69 |
Lipg |
lipase, endothelial |
4701 |
0.11 |
chr13_84571624_84571828 | 13.67 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr4_120332877_120333106 | 13.65 |
Foxo6os |
forkhead box O6, opposite strand |
41641 |
0.15 |
chr7_61939801_61940302 | 13.64 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr4_110287470_110287673 | 13.63 |
Elavl4 |
ELAV like RNA binding protein 4 |
44 |
0.99 |
chr2_109678555_109678726 | 13.62 |
Bdnf |
brain derived neurotrophic factor |
1608 |
0.32 |
chr12_46520967_46521283 | 13.52 |
Gm7422 |
predicted gene 7422 |
41798 |
0.18 |
chr9_94410108_94410502 | 13.48 |
Gm5370 |
predicted gene 5370 |
2179 |
0.35 |
chr2_10293635_10293822 | 13.48 |
Sfmbt2 |
Scm-like with four mbt domains 2 |
76782 |
0.03 |
chr12_120015533_120015684 | 13.47 |
Gm27236 |
predicted gene 27236 |
15081 |
0.24 |
chr11_35203810_35203973 | 13.46 |
Gm26070 |
predicted gene, 26070 |
10510 |
0.24 |
chr14_104298418_104298592 | 13.45 |
D130079A08Rik |
RIKEN cDNA D130079A08 gene |
160811 |
0.04 |
chr15_8659976_8660428 | 13.41 |
Gm37310 |
predicted gene, 37310 |
5129 |
0.23 |
chr8_86389721_86389961 | 13.39 |
Gm24490 |
predicted gene, 24490 |
97340 |
0.07 |
chr9_10681606_10682000 | 13.36 |
Gm7529 |
predicted gene 7529 |
52837 |
0.17 |
chr1_51216342_51216995 | 13.36 |
Gm29325 |
predicted gene 29325 |
21447 |
0.19 |
chr15_66239660_66240017 | 13.33 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr9_37625246_37625717 | 13.32 |
Siae |
sialic acid acetylesterase |
3827 |
0.14 |
chr9_105379897_105380048 | 13.31 |
Nek11 |
NIMA (never in mitosis gene a)-related expressed kinase 11 |
13049 |
0.16 |
chrX_110318504_110318684 | 13.31 |
Gm7134 |
predicted gene 7134 |
54159 |
0.18 |
chr8_112268552_112269162 | 13.30 |
Gm3635 |
predicted gene 3635 |
31891 |
0.23 |
chr5_147155070_147155280 | 13.30 |
Gsx1 |
GS homeobox 1 |
33521 |
0.11 |
chr11_16299934_16300272 | 13.27 |
Vstm2a |
V-set and transmembrane domain containing 2A |
36885 |
0.19 |
chr6_47239363_47240145 | 13.18 |
Cntnap2 |
contactin associated protein-like 2 |
4633 |
0.33 |
chr6_148615895_148616290 | 13.18 |
Gm6313 |
predicted gene 6313 |
1783 |
0.35 |
chr4_151696178_151696329 | 13.16 |
Camta1 |
calmodulin binding transcription activator 1 |
165397 |
0.03 |
chr10_30327889_30328266 | 13.15 |
Gm4780 |
predicted gene 4780 |
44841 |
0.17 |
chr4_87651182_87651681 | 13.14 |
Gm12604 |
predicted gene 12604 |
70642 |
0.13 |
chr5_103160967_103161542 | 13.12 |
Mapk10 |
mitogen-activated protein kinase 10 |
44675 |
0.17 |
chr4_88211578_88211756 | 13.11 |
Gm12645 |
predicted gene 12645 |
59971 |
0.11 |
chr16_77648330_77648508 | 13.10 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
2079 |
0.17 |
chr8_67972439_67972650 | 13.09 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
2030 |
0.35 |
chr16_49193672_49193981 | 13.07 |
1700026J12Rik |
RIKEN cDNA 1700026J12 gene |
61946 |
0.12 |
chr11_112869991_112870994 | 13.06 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
45313 |
0.16 |
chr15_88360840_88360991 | 13.04 |
4930445N06Rik |
RIKEN cDNA 4930445N06 gene |
45283 |
0.16 |
chr10_36534044_36534213 | 13.02 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
26721 |
0.24 |
chr13_21005724_21006043 | 13.01 |
Aoah |
acyloxyacyl hydrolase |
4750 |
0.24 |
chr16_51589915_51590114 | 12.99 |
Gm49608 |
predicted gene, 49608 |
173066 |
0.04 |
chrX_69666420_69666593 | 12.99 |
Gm8172 |
predicted pseudogene 8172 |
60261 |
0.15 |
chr8_74557794_74557991 | 12.98 |
Gm11033 |
predicted gene 11033 |
276028 |
0.01 |
chr10_23449639_23449790 | 12.97 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
98928 |
0.07 |
chr5_111725288_111725497 | 12.96 |
Gm26897 |
predicted gene, 26897 |
8532 |
0.19 |
chr2_60654945_60655277 | 12.96 |
Itgb6 |
integrin beta 6 |
18582 |
0.2 |
chr2_94246412_94247550 | 12.96 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr1_31233663_31234000 | 12.94 |
Pih1d3 |
PIH1 domain containing 3 |
10993 |
0.12 |
chr12_51081982_51082133 | 12.93 |
Gm22088 |
predicted gene, 22088 |
3630 |
0.28 |
chr1_57862082_57862411 | 12.92 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
16675 |
0.22 |
chr13_85067648_85067905 | 12.92 |
Gm47745 |
predicted gene, 47745 |
26559 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.5 | 62.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
9.9 | 29.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
9.1 | 27.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
8.9 | 26.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
8.7 | 26.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
8.4 | 33.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
7.3 | 51.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
6.8 | 20.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
5.8 | 17.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.6 | 16.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
5.3 | 21.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
4.7 | 14.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.6 | 13.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
4.6 | 4.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.5 | 4.5 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
4.2 | 21.2 | GO:0021764 | amygdala development(GO:0021764) |
4.2 | 16.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
4.0 | 12.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
4.0 | 31.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.9 | 15.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
3.9 | 11.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.8 | 11.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.8 | 7.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.8 | 18.9 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
3.8 | 15.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.7 | 11.2 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.7 | 18.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.7 | 11.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
3.7 | 11.0 | GO:0007525 | somatic muscle development(GO:0007525) |
3.6 | 10.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.6 | 32.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.5 | 17.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
3.5 | 13.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.4 | 10.3 | GO:0030070 | insulin processing(GO:0030070) |
3.4 | 20.6 | GO:0071625 | vocalization behavior(GO:0071625) |
3.4 | 10.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.4 | 10.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.3 | 3.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.2 | 13.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
3.2 | 9.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
3.2 | 9.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.2 | 12.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.2 | 12.7 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.2 | 9.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.2 | 15.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.1 | 3.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.1 | 24.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.0 | 3.0 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) auditory receptor cell fate determination(GO:0042668) negative regulation of pro-B cell differentiation(GO:2000974) |
3.0 | 21.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
3.0 | 9.0 | GO:0035106 | operant conditioning(GO:0035106) |
3.0 | 18.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.0 | 6.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
3.0 | 3.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.0 | 11.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.9 | 2.9 | GO:0022038 | corpus callosum development(GO:0022038) |
2.9 | 8.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.8 | 16.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
2.8 | 8.4 | GO:0060594 | mammary gland specification(GO:0060594) |
2.8 | 8.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.8 | 13.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.7 | 8.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.7 | 8.1 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.7 | 18.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
2.6 | 10.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.5 | 7.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.4 | 7.3 | GO:0021564 | vagus nerve development(GO:0021564) |
2.4 | 7.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.4 | 16.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.4 | 4.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.4 | 7.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.4 | 7.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.4 | 2.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.3 | 2.3 | GO:0021550 | medulla oblongata development(GO:0021550) |
2.3 | 7.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.3 | 9.2 | GO:0060513 | prostatic bud formation(GO:0060513) |
2.3 | 6.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.3 | 4.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
2.3 | 6.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.2 | 2.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.2 | 49.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
2.2 | 20.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.2 | 6.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.2 | 6.5 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.2 | 6.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.1 | 2.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.1 | 8.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
2.1 | 2.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
2.0 | 12.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
2.0 | 16.3 | GO:0050957 | equilibrioception(GO:0050957) |
2.0 | 12.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.0 | 4.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.0 | 2.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.0 | 10.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.0 | 6.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.0 | 7.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.0 | 7.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.0 | 11.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.9 | 5.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.9 | 5.8 | GO:0001927 | exocyst assembly(GO:0001927) |
1.9 | 3.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.9 | 11.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.9 | 5.8 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.9 | 5.7 | GO:0030035 | microspike assembly(GO:0030035) |
1.9 | 5.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.9 | 13.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.9 | 5.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.9 | 31.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.9 | 1.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.9 | 1.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.8 | 9.1 | GO:0019532 | oxalate transport(GO:0019532) |
1.8 | 1.8 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
1.8 | 16.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.8 | 10.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.8 | 7.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.8 | 5.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.8 | 5.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.7 | 7.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.7 | 3.5 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.7 | 5.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.7 | 5.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.7 | 5.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.7 | 6.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 11.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.7 | 18.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.7 | 25.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.7 | 5.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.6 | 6.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.6 | 4.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.6 | 9.8 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.6 | 1.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.6 | 8.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.6 | 4.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.6 | 3.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.6 | 11.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.6 | 11.0 | GO:0060539 | diaphragm development(GO:0060539) |
1.6 | 7.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.6 | 4.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.6 | 3.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.5 | 4.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.5 | 9.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.5 | 15.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.5 | 82.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.5 | 7.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.5 | 4.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.5 | 3.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.5 | 28.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.5 | 3.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.5 | 5.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.4 | 14.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.4 | 1.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.4 | 4.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.4 | 1.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.4 | 7.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.4 | 5.6 | GO:0048664 | neuron fate determination(GO:0048664) |
1.4 | 2.8 | GO:0090135 | actin filament branching(GO:0090135) |
1.4 | 5.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.4 | 4.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.4 | 5.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.4 | 4.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.4 | 5.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.4 | 104.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.4 | 12.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.4 | 2.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.4 | 2.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 4.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.4 | 6.8 | GO:0030432 | peristalsis(GO:0030432) |
1.3 | 2.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.3 | 5.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.3 | 10.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.3 | 2.6 | GO:0071435 | potassium ion export(GO:0071435) |
1.3 | 6.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.3 | 5.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.3 | 3.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.3 | 2.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.3 | 3.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 3.9 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.3 | 10.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.3 | 5.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.3 | 3.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.3 | 3.8 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.3 | 5.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.3 | 3.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.3 | 3.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.2 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.2 | 7.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.2 | 2.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.2 | 1.2 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
1.2 | 3.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 2.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.2 | 8.6 | GO:0006108 | malate metabolic process(GO:0006108) |
1.2 | 2.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.2 | 3.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.2 | 4.9 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.2 | 4.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.2 | 4.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.2 | 9.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.2 | 2.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.2 | 2.4 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
1.2 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 2.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.2 | 5.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.2 | 8.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.2 | 14.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.2 | 1.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.2 | 7.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.2 | 2.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
1.2 | 2.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.2 | 3.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.1 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.1 | 9.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
1.1 | 3.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.1 | 3.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 3.3 | GO:0060437 | lung growth(GO:0060437) |
1.1 | 2.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.1 | 3.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
1.1 | 13.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.1 | 1.1 | GO:0021825 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) facioacoustic ganglion development(GO:1903375) dorsal root ganglion development(GO:1990791) |
1.1 | 2.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.1 | 4.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.1 | 3.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 7.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.1 | 6.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.1 | 18.3 | GO:0001964 | startle response(GO:0001964) |
1.1 | 5.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.1 | 2.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.1 | 6.4 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.1 | 5.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.1 | 2.1 | GO:0001757 | somite specification(GO:0001757) |
1.1 | 3.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.1 | 4.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.1 | 6.4 | GO:0060179 | male mating behavior(GO:0060179) |
1.1 | 10.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.0 | 3.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.0 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.0 | 2.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.0 | 3.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.0 | 8.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.0 | 2.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.0 | 3.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.0 | 7.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.0 | 7.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
1.0 | 1.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.0 | 1.0 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.0 | 3.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 3.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.0 | 5.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 2.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.0 | 2.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
1.0 | 6.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.0 | 3.9 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.0 | 3.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 2.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.0 | 2.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.0 | 6.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.0 | 1.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.9 | 3.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.9 | 2.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 2.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.9 | 1.9 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.9 | 0.9 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.9 | 6.5 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.9 | 3.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.9 | 2.7 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.9 | 5.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 2.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.9 | 1.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 0.9 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.9 | 1.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.9 | 1.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.9 | 5.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.9 | 3.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.9 | 22.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.9 | 74.4 | GO:0007612 | learning(GO:0007612) |
0.9 | 2.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.9 | 15.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.9 | 1.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.9 | 3.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 8.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.8 | 2.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 1.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.8 | 2.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.8 | 2.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 2.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 1.7 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.8 | 2.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.8 | 9.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.8 | 2.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 6.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.8 | 1.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.8 | 5.7 | GO:0021544 | subpallium development(GO:0021544) |
0.8 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.8 | 7.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.8 | 1.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.8 | 0.8 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.8 | 0.8 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.8 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 2.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 0.8 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.8 | 1.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.8 | 1.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 0.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.8 | 1.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.8 | 5.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 7.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.8 | 2.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.8 | 4.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.7 | 2.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 5.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 2.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.7 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.7 | 1.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 1.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.7 | 6.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.7 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.7 | 2.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 1.4 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.7 | 3.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 2.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.7 | 2.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.7 | 2.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.7 | 2.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 11.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 3.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.7 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 1.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.7 | 4.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.7 | 2.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.7 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.7 | 0.7 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.7 | 2.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.7 | 12.4 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.7 | 3.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.7 | 13.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.6 | 4.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 2.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.6 | 3.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.6 | 1.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 3.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.6 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 6.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 1.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 4.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.6 | 3.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 8.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.6 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.6 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 1.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 1.2 | GO:0021548 | pons development(GO:0021548) |
0.6 | 2.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 3.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 1.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 6.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.6 | 0.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.6 | 2.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 1.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 2.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 3.4 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 2.2 | GO:0090148 | membrane fission(GO:0090148) |
0.6 | 15.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 5.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 3.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 1.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.5 | 3.8 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 2.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 2.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 0.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 0.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 0.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.5 | 1.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.5 | 1.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.5 | 5.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 1.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 3.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 3.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 1.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.4 | GO:0021794 | thalamus development(GO:0021794) |
0.5 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.5 | 0.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 15.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.5 | 1.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.5 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.5 | 0.9 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.4 | 3.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 6.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.4 | 1.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 0.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 0.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 0.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 6.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 1.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 1.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 1.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 1.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 3.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 2.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 2.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 1.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.4 | 4.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 5.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 1.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 2.8 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 0.8 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.4 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 1.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 3.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 2.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 0.4 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.4 | 1.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 3.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.4 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.4 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 1.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 1.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.4 | 0.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.4 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 0.4 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.4 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 1.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 5.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 2.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.7 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 1.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.7 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.3 | 1.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 5.6 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.3 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 4.9 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 2.6 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 1.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 1.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.6 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 1.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.9 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.9 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 4.8 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.3 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.9 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.3 | 3.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 2.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 2.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 1.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.3 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.3 | 0.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.3 | GO:0072044 | collecting duct development(GO:0072044) |
0.3 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.7 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 3.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 0.5 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 2.5 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.2 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 1.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 2.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.2 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.4 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.8 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.2 | 1.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.4 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 2.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 1.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.2 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.4 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 5.6 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.8 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.2 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.2 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.3 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 1.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 2.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 4.3 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 7.0 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.1 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.4 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.1 | 0.5 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.4 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.1 | GO:0071639 | regulation of interleukin-18 production(GO:0032661) positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 1.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.0 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 13.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.5 | 19.6 | GO:0072534 | perineuronal net(GO:0072534) |
6.1 | 60.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.1 | 20.4 | GO:0033010 | paranodal junction(GO:0033010) |
4.6 | 13.7 | GO:0097441 | basilar dendrite(GO:0097441) |
4.5 | 22.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.5 | 35.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.0 | 15.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.2 | 47.8 | GO:0031527 | filopodium membrane(GO:0031527) |
3.1 | 21.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.9 | 29.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.8 | 5.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.6 | 18.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.4 | 19.6 | GO:0043083 | synaptic cleft(GO:0043083) |
2.4 | 4.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.4 | 9.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.3 | 6.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.3 | 15.8 | GO:0071437 | invadopodium(GO:0071437) |
2.1 | 8.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.1 | 2.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.0 | 4.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.9 | 5.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.8 | 47.3 | GO:0044295 | axonal growth cone(GO:0044295) |
1.8 | 9.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.8 | 7.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.8 | 5.4 | GO:0070552 | BRISC complex(GO:0070552) |
1.8 | 17.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.8 | 10.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 44.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.7 | 5.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.6 | 3.3 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.6 | 9.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.6 | 34.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.6 | 18.7 | GO:0071564 | npBAF complex(GO:0071564) |
1.5 | 4.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.5 | 4.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.5 | 22.3 | GO:0031045 | dense core granule(GO:0031045) |
1.4 | 48.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 18.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.3 | 7.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 5.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 5.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.3 | 7.7 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 14.1 | GO:0042555 | MCM complex(GO:0042555) |
1.3 | 8.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.2 | 9.7 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 3.4 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 10.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.1 | 4.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.1 | 8.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.1 | 5.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.1 | 1.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 164.5 | GO:0060076 | excitatory synapse(GO:0060076) |
1.0 | 6.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 9.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.0 | 3.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 4.5 | GO:0097433 | dense body(GO:0097433) |
0.9 | 2.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 8.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 2.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.8 | 2.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 7.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 7.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.8 | 5.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 4.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 3.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.7 | 17.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 78.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.7 | 5.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 37.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 4.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 7.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 7.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.6 | 3.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 6.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 3.0 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 1.8 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.6 | 1.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 2.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 1.6 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 3.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 3.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 3.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 6.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 4.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 7.0 | GO:0043205 | fibril(GO:0043205) |
0.5 | 7.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.2 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 5.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 8.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 4.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 5.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 4.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 3.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 6.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 3.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 3.6 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 4.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 4.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 2.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 5.9 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.6 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 2.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 3.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 5.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 4.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 3.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 26.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.1 | 21.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
7.1 | 28.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
6.2 | 31.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.8 | 23.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
5.5 | 16.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.9 | 24.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.7 | 9.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
4.4 | 13.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
4.4 | 21.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.1 | 28.7 | GO:0003680 | AT DNA binding(GO:0003680) |
3.9 | 23.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.6 | 7.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.4 | 13.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.2 | 9.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.9 | 8.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.7 | 24.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.6 | 5.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
2.6 | 7.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.6 | 7.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.5 | 10.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.4 | 7.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.4 | 9.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
2.4 | 4.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.2 | 6.7 | GO:0097016 | L27 domain binding(GO:0097016) |
2.2 | 6.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.1 | 10.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.1 | 8.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.0 | 6.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.0 | 2.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.0 | 6.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.0 | 39.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.0 | 7.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.9 | 11.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 7.7 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.8 | 20.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.8 | 10.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.8 | 19.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.8 | 7.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.8 | 7.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.8 | 9.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.8 | 14.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.8 | 3.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.7 | 7.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.7 | 1.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.7 | 5.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.7 | 38.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.6 | 4.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.6 | 3.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.6 | 4.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.6 | 4.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.6 | 7.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.6 | 6.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.6 | 18.9 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
1.5 | 6.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.5 | 7.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.5 | 4.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.4 | 2.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.4 | 7.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.4 | 5.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.4 | 11.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.4 | 7.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.4 | 7.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.4 | 5.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.4 | 5.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.4 | 6.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.3 | 12.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 2.6 | GO:0043199 | sulfate binding(GO:0043199) |
1.3 | 2.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.3 | 8.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.2 | 3.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 3.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.2 | 28.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.2 | 6.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 7.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.2 | 4.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.2 | 3.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.2 | 3.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.1 | 3.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.1 | 4.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.1 | 4.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 2.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.1 | 2.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.1 | 5.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 7.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 5.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.1 | 4.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 1.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.1 | 5.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.0 | 21.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 5.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.0 | 11.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.0 | 6.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 9.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 3.0 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 13.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.0 | 2.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.9 | 2.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 2.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 3.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 10.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 16.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.9 | 2.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.9 | 4.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.9 | 2.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.9 | 21.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.9 | 5.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.8 | 11.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 5.0 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 2.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.8 | 8.8 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.8 | 3.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 4.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 28.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.8 | 3.0 | GO:0034618 | arginine binding(GO:0034618) |
0.8 | 3.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 2.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 3.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 6.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 4.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 2.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.7 | 5.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.7 | 4.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 5.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 6.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.7 | 15.7 | GO:0034840 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.7 | 3.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.7 | 5.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 1.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 1.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 1.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 20.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 5.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 7.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 1.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.6 | 2.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 4.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 6.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 2.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 2.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 2.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.6 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 3.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 9.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 6.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 2.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 5.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 10.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 15.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 2.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 2.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 13.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 2.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 2.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 15.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 3.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 13.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 1.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.5 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 7.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 11.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 3.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.5 | 11.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.5 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.5 | 1.5 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.5 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 2.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 0.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 2.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 2.7 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.5 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 5.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 1.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 7.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 2.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 1.7 | GO:0032564 | dATP binding(GO:0032564) |
0.4 | 2.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 4.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 5.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 2.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 1.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 11.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 3.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 6.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 2.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 0.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.4 | 1.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 3.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 3.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 2.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 4.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0018598 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 2.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 4.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 3.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 3.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 2.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 6.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 2.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 9.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 5.2 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 9.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.9 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.2 | 14.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 1.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 4.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.9 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 16.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 27.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.3 | 24.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 30.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.8 | 10.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 19.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 6.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 1.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 11.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 15.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 4.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 5.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 10.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 5.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 6.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 12.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 4.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 6.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 29.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.4 | 26.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.3 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.8 | 18.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.7 | 55.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.6 | 18.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.6 | 11.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 4.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.4 | 30.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 10.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.3 | 1.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.3 | 9.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.3 | 15.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.2 | 19.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.2 | 17.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 3.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
1.1 | 20.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.0 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.9 | 1.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 10.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 11.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 15.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 6.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 8.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 7.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 8.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.8 | 5.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 11.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 15.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 10.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.7 | 5.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.7 | 1.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.7 | 9.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 7.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.6 | 23.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 10.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 5.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 11.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 6.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 15.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.5 | 3.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 6.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 2.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 3.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 5.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 5.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 9.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 7.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 4.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 2.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 3.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 2.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 3.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 3.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 1.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 3.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 7.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 6.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 4.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |